TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2023)
Powered by 
Analysis
TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 7.44% |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 9.71% |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1.99% |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 2.94% |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 1.35% |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 5.67% |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 13.89% |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 1.70% |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -96.55% |
| Jun 30, 2023 | -94.51% |
| Mar 31, 2023 | -94.64% |
| Dec 31, 2022 | -90.52% |
| Sep 30, 2022 | -60.30% |
| Jun 30, 2022 | -56.89% |
| Mar 31, 2022 | -40.29% |
| Dec 31, 2021 | -57.62% |
| Sep 30, 2021 | -29.54% |
| Jun 30, 2021 | -23.25% |
| Mar 31, 2021 | -22.24% |
| Dec 31, 2020 | -22.56% |
| Sep 30, 2020 | -15.76% |
| Jun 30, 2020 | 49.84% |
| Dec 31, 2019 | 430.54% |
| Sep 30, 2019 | 512.25% |
| Jun 30, 2019 | 254.86% |
| Dec 31, 2018 | 8.15% |
| Sep 30, 2018 | -14.76% |
| Jun 30, 2018 | -16.56% |